Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Uterine Cervical Neoplasms × TP protocol × Clear all

Phase

Status

Unknown 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Squamous Cell Carcinoma 3 Uterine Cervical Neoplasms 1 Esophageal Neoplasms 1

Interventions

pembrolizumab 17 Cisplatin 14 Carboplatin 10 Bevacizumab 9 Radiotherapy 8 Paclitaxel 8 Drug Therapy 7 Colposcopy 6 Brachytherapy 6 Blood Specimen Collection 6 Specimen Handling 5 camrelizumab 4 Nivolumab 4 Injections 4 Human Papillomavirus DNA Tests 4 Gemcitabine 4 Chemotherapy, Adjuvant 4 Chemoradiotherapy 4 toripalimab 3 Taxes 3 Surveys and Questionnaires 3 Mass Screening 3 Fulvestrant 3 Cyclophosphamide 3 Biopsy 3 zimberelimab 2 spartalizumab 2 lenvatinib 2 fludarabine 2 dostarlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04409860 2023-04-11

CQGOG0102

Chongqing University Cancer Hospital

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡